N-acetylcysteine (NAC) and glutathione (GSH): antioxidant and chemopreventive properties, with special reference to lung cancer.
Level 5 - mechanism / opinion, no new human data
Narrative review of biochemical mechanisms without original clinical or trial data.
PubMed 8538205 · doi:10.1002/jcb.240590805
What was done
This narrative review examined the mechanistic rationale for using N-acetylcysteine and glutathione as chemopreventive agents against cigarette smoke-induced lung carcinogenesis.
What was found
The abstract reports no numerical data or clinical trial metrics. It describes how carcinogenesis depends on the balance between metabolic activation and detoxification, radical formation and scavenging, and DNA damage and repair. N-acetylcysteine is characterized as a clinically safe mucolytic drug and glutathione precursor with antimutagenic and anticarcinogenic properties mediated by nucleophilicity, antioxidant activity, modulation of detoxification, and facilitation of DNA repair.
Why it matters
The paper outlines the biochemical basis for considering N-acetylcysteine as a potential chemopreventive candidate in tobacco-exposed populations.
Limits
The abstract contains no empirical data, sample sizes, or systematic review methodology. Proposed biochemical mechanisms do not demonstrate clinical cancer prevention in humans.
Cited by
- supports N-acetylcysteine (NAC) supplementation supports endogenous glutathione production and detoxification.